An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension
This study has been terminated.
Study NCT00449111
Information provided by Merck
First Received: March 16, 2007
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
